Mark Barakat, MD

Mark Barakat, MD, reviews the best practices for patient communication and shared decision making.

Mark Barakat, MD, discusses the phase 3 TENAYA and LUCERNE trials for patients with neovascular age-related macular degeneration (nAMD).